Hormonal Therapy for Acne in Teenage Females
Hormonal therapy for acne in teenage females includes combined oral contraceptives (COCs), spironolactone, and topical clascoterone, with COCs being the only FDA-approved hormonal option specifically indicated for acne treatment in women who also desire contraception. 1
Combined Oral Contraceptives (COCs)
COCs are conditionally recommended as first-line hormonal therapy based on moderate certainty evidence and should be considered for any teenage female with acne who also desires contraception. 1
FDA-Approved Formulations for Acne
Four specific COC formulations have FDA approval for acne treatment in women desiring oral contraception 1:
- Norgestimate/ethinyl estradiol (EE)
- Norethindrone acetate/EE/ferrous fumarate
- Drospirenone/EE
- Drospirenone/EE/levomefolate
All are available in generic forms in the US.
Mechanism and Efficacy
COCs work through anti-androgenic properties by:
- Decreasing ovarian androgen production
- Increasing sex hormone-binding globulin
- Reducing free testosterone
- Reducing 5α-reductase activity
- Blocking androgen receptors 1
Clinical outcomes show COCs achieve 1.45 times greater IGA success compared to placebo at 6 months, with significant reductions in both inflammatory and noninflammatory lesions. 1
Important Considerations
All COC formulations demonstrate generally similar efficacy for acne treatment, so selection should be based on patient preferences, contraceptive needs, comorbidity profile, access, and cost. 2 The specific progestin generation matters less when combined with estrogen, as all COCs yield net anti-androgenic properties 1.
Critical caveat: Progestin-only contraceptives (pills, injections, IUDs, or implants) may worsen acne and should be avoided in acne patients. 1
Spironolactone
Spironolactone is an effective off-label hormonal therapy with clinical trial data supporting its use as first-line treatment for women with acne. 2
Dosing and Efficacy in Adolescents
In adolescent females (median age 19 years, range 14-20):
- 80% experienced improvement on spironolactone 3
- Median effective dose: 100 mg daily
- 22.5% achieved complete response
- 58.8% had complete or >50% partial response
- Initial response: median 3 months
- Maximal response: median 5 months
- Treatment duration: median 7 months (range 3-45 months) 3
Safety Profile
Spironolactone demonstrates a favorable side effect profile and is a safe long-term alternative to systemic antibiotics in adolescent females. 3 Potassium monitoring is of low value unless patients have specific risk factors for hyperkalemia. 2
Topical Clascoterone
Clascoterone is a topical anti-androgen FDA-approved for acne treatment in both males and females, with limited systemic effects on reproductive hormones. 2 This represents a newer option with good efficacy and safety profile, particularly valuable for patients who cannot or prefer not to use systemic hormonal therapy 2, 4.
Clinical Algorithm for Teenage Females
First consideration: Does the patient desire or need contraception?
- Yes: COCs are the preferred hormonal option (FDA-approved indication)
- No: Consider spironolactone or topical clascoterone
If COCs selected: Choose any of the four FDA-approved formulations based on patient preference, access, and cost—efficacy is similar across formulations
If spironolactone selected: Start with 50-100 mg daily, expect response at 3 months, optimize at 5 months
If topical therapy preferred: Clascoterone offers hormonal benefits without systemic reproductive hormone effects
Common Pitfalls to Avoid
- Never prescribe progestin-only contraceptives to acne patients—they may worsen acne 1
- Do not unnecessarily monitor potassium in healthy adolescents on spironolactone without risk factors 2
- Recognize that hormonal therapy works through different mechanisms than antibiotics and retinoids, making it valuable for combination therapy or antibiotic-sparing strategies 5, 6
- Hormonal therapies benefit women with acne even without elevated serum androgens—hyperandrogenism screening is not required before initiating treatment 6